On Tuesday, 1998 stocks advanced, 2181 declined and 183 remained unchanged on Bombay Stock Exchange with advance decline ratio of 0.91 indicating a negative closing. The trend of the major indices on Tuesday’s trading is given in the table below.
On NSE, 116 securities advanced and closed at a new 52-week high whereas 24 securities sank to close at their new 52-week lows. Nifty India Defence, Nifty FMCG and Nifty Auto were among the biggest gainers. Nifty Infrastructure and Nifty PSU Bank were among the biggest losers.
RBL Bank (+0.83%) received SEBI’s prior approval for the proposed preferential equity investment by Emirates NBD Bank. Deal remains subject to additional regulatory clearances and customary conditions under the Investment Agreement.
Premier Explosives (+0.64%) secured a ₹33.69 crore export order for rocket motors, to be delivered in 18 months. This deal highlights the company’s ability to consistently win international contracts, positioning it as a credible Indian player in the global defence supply chain.
Bharat Electronics (-0.05%) (BEL) has secured a ₹1,251 crore contract from the Ministry of Defence for the supply of Ground Based Mobile ELINT System (GBMES) to the Indian Army. It detects, classifies, and locates all radar types; intercepts and analyses communication signals, enhancing situational awareness and air defence. Its networked intelligence system strengthens operational capabilities, offering a modern warfare edge through comprehensive signal processing.
Caplin Steriles Ltd. (CSL), the wholly owned arm of Caplin Point Laboratories (+0.30%), has received final USFDA approval for its Calcium Gluconate Injection USP across multiple vial formats, tapping into a US$71 mn market, strengthening its US hospital generics portfolio.
Lupin (-0.23%) secured USFDA approval for Glycerol Phenylbutyrate Oral Liquid, bioequivalent to Ravicti, tapping into a US$337 mn urea cycle disorders (UCDs) market, reinforcing its US specialty generics presence. This approval underscores Lupin’s push into rare disease therapies, diversifying beyond mainstream generics into specialty segments with meaningful commercial potential.
South West Pinnacle (-6.41%) FY26 revenue rose 35% y o y to ₹243 crore, while PAT more than doubled to ₹33 crore, indicating sharp profitability improvement.
Coforge (+1.49%) Q4 FY26 revenue rose 30% y‑o‑y to ₹4,450.4 crore, with Net Profit more than doubling to ₹612.3 crore; margins expanded sharply, driving EPS growth of 134% y‑o‑y.
Marico (+2.89%) Q4 FY26 revenue rose 22.1% y‑o‑y to ₹3,333 crore, while Net Profit grew 14% y‑o‑y to ₹391 crore.
Mahindra & Mahindra Q4 FY26 revenue rose 25.3% y‑o‑y to ₹39,601 crore, with Net Profit up 53.4% y‑o‑y to ₹3,737 crore; margins expanded y‑o‑y but softened sequentially, reflecting SUV‑led strength amid cost pressures.
Tata Chemicals (-0.53%) Q4 FY26 revenue fell 2% y o y, while Net Profit widened to a ₹279 crore loss, underscoring pressure from weak US export realizations despite India volume gains.
The top gainers and top losers of the major indices are given in the table below:
The closing values of the major Asian indices are given in the table below:
Waaree Renewable: Growth Story Faces Grid and Order-book Constraints
Moneylife Digital Team
05 May 2026
Waaree Renewable Technologies (Waaree Renewable), a subsidiary of Waaree Energies and part of the Waaree group, reported a 66% year-on-year (y-o-y) surge in net profit for Q4FY25-26, driven by India's accelerating solar sector growth....
JNK India: Order-book Visibility, Joint Venture Optionality
Moneylife Digital Team
05 May 2026
JNK India Limited (JNK India) is a Mumbai-based technology-driven EPC (engineering-procurement-construction) company incorporated in 2010, specialising in combustion equipment for the oil, gas, petrochemicals and fertiliser...
Amanta Healthcare Expands Capacity, Targets Higher Profitability
Moneylife Digital Team
05 May 2026
Amanta Healthcare Limited (Amanta) operates within the niche sterile liquid pharmaceuticals segment, primarily supplying hospitals and institutional clients across domestic and export markets. Historically, the investment thesis has...
Market This Week
Moneylife Digital Team
30 April 2026
Moneylife’s market breadth indicators have maintained their position in bullish territory for the past two weeks, marking a continuation of the rare strength seen in early-April. The trends of the major indices in the course of the...
